Kimberley A. Elting
CIK 1605209 · President, Global Orthopedics · last filed 2024-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.23M
Companies
2
Total Filings
38
Lifetime Open-Market Net
-$397.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OFIX | President, Global Orthopedics | 227,747 | $9.78 | $2.23M | -$397.0K | 36 | 2024-06-12 |
| TriVascular Technologies, Inc. (TRIV) Delisted | VP, Gen. Counsel and Secretary | 14,221 | — | — | $0 | 2 | 2016-02-04 |
Recent Filings · Page 3 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-28 | OFIX | Tax (F) | −550 | -$16.2K | EDGAR |
| 2020-09-15 | OFIX | Tax (F) | −365 | -$10.5K | EDGAR |
| 2020-07-06 | OFIX | Tax (F) | −346 | -$11.1K | EDGAR |
| 2020-06-10 | OFIX | Grant (A) | — | $0 | EDGAR |
| 2020-04-03 | OFIX | Mixed | +7,747 | -$18.1K | EDGAR |
| 2019-09-27 | OFIX | Tax (F) | −550 | -$29.8K | EDGAR |
| 2019-09-06 | OFIX | Tax (F) | −365 | -$18.5K | EDGAR |
| 2019-07-15 | OFIX | Tax (F) | −346 | -$17.9K | EDGAR |
| 2019-04-11 | OFIX | Tax (F) | −335 | $0 | EDGAR |
| 2019-04-03 | OFIX | Grant (A) | +11,190 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.